|
03 May 2007 |
Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of Expressed RNAi Approach to Treating Chronic Hepatitis B Infections
|
|
02 May 2007 |
Cardium Advancing Excellarate to Phase 2b Clinical Study
|
|
02 May 2007 |
University College London, Moorfields Eye Hospital and Targeted Genetics Initiate Phase I/II Clinical Trial of Gene Therapy for Childhood Blindness
|
|
01 May 2007 |
Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
|
|
01 May 2007 |
New Report Illuminates Ampligen(R)'s Unique Mechanism of Action
|
|
28 Apr 2007 |
CHMP Adopts Negative Opinion on Genasense(R) Application in Melanoma
|
|
28 Apr 2007 |
Ark Therapeutics Grp - Regulatory Update
|
|
27 Apr 2007 |
Sangamo BioSciences Initiates Additional Phase 2 Clinical Trial of Novel Therapy for Moderate to Severe Diabetic Neuropathy
|
|
25 Apr 2007 |
Ark Therapeutics Grp - Research Update
|
|
19 Apr 2007 |
Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
|
|
18 Apr 2007 |
Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference
|
|
18 Apr 2007 |
Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
|
|
18 Apr 2007 |
Introgen's Intravenous Nanoparticle Gene Therapy Shows Activity in Stage IV Lung Cancer Patients
|
|
18 Apr 2007 |
ProNAi Announces Preclinical Success for PNT2258 Therapeutic – Curative Events in Xenograft Mice for Difficult-to-Treat Non-Hodgkin's Lymphoma
|
|
17 Apr 2007 |
Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
|
|
17 Apr 2007 |
Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinson's Patients
|
|
17 Apr 2007 |
Regulatory Review Allows LCT Diabetes Clinical Program to Proceed
|
|
17 Apr 2007 |
Bioniche Presents Additional Data on the Anticancer Activity of MCC Against Peritoneal Carcinomatosis
|
|
14 Apr 2007 |
Ceregene Enrolling Patients For Phase 2 Clinical Trial Of Parkinson's Disease
|
|
12 Apr 2007 |
Oncolytics Biotech Inc. Proceeds to Initiate U.S. Phase II Sarcoma Clinical Trial
|
|
12 Apr 2007 |
Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals
|
|
05 Apr 2007 |
Genta Appeals FDA Decision on Genasense in CLL
|
|
31 Mar 2007 |
LCT reports major step forward for islet transplantation in diabetes patient
|
|
27 Mar 2007 |
Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC
|
|
26 Mar 2007 |
Osiris Therapeutics Announces Positive Results in Groundbreaking Stem Cell Trial to Treat Heart Disease
|
